Zoledronate-induced scleritis: Clinical characteristics, management, and outcomes

Zoledronate-induced scleritis: Clinical characteristics, management, and outcomes

Saved in:

Bibliographic Details
Main Authors:	Dan He, Can Xiao, Guohua Li, Sha Zeng
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Asian Journal of Surgery
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958424013332
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Infectious scleritis: a review of etiologies, clinical features, and management strategies
by: Supriya Sharma, et al.
Published: (2025-02-01)

Author Response: Comment on Surgically induced necrotizing scleritis (SINS): Is it a standalone condition or a variant of necrotizing scleritis?
by: Kowsigan Magesan, et al.
Published: (2024-12-01)

Thermography in posterior scleritis
by: A. Kawali, et al.
Published: (2020-11-01)

Recurrent scleritis: A case report
by: Hui Dong, et al.
Published: (2025-01-01)

Scleritis and episcleritis in patients with idiopathic small fiber neuropathy
by: Atitaya Apivatthakakul, et al.
Published: (2024-12-01)

Wide-field fluorescein angiography findings in active anterior scleritis
by: Juan C. Romo-Aguas, et al.
Published: (2024-12-01)

New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy
by: Claudia Fabiani, et al.
Published: (2020-01-01)

IgG4-Related Disease Presenting as Isolated Scleritis
by: Eran Berkowitz, et al.
Published: (2017-01-01)

Aspergillus fumigatus Endophthalmitis with Necrotizing Scleritis following Pars Plana Vitrectomy
by: Anna M. Gruener, et al.
Published: (2016-01-01)

Developing the biomarker panels and drugs by proteomic analysis for autoimmune uveitis and posterior scleritis
by: Xueru Li, et al.
Published: (2024-12-01)

Clinico-Microbiological Profile and Treatment Outcome of Infectious Scleritis: Experience from a Tertiary Eye Care Center of India
by: Srikant Kumar Sahu, et al.
Published: (2012-01-01)

Zoledronate interrupts pre-osteoclast-induced angiogenesis via SDF-1/CXCR4 pathway
by: Mohamed Awad, et al.
Published: (2024-12-01)

Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer
by: Bruno de Paula, et al.
Published: (2025-01-01)

Zoledronic Acid Inhibits Lipopolysaccharide‐Induced Osteoclastogenesis by Suppressing Macrophage NLRP3‐Mediated Autophagy Pathway
by: Yuting Cheng, et al.
Published: (2024-12-01)

Characteristics Associated with Acute-Phase Response following First Zoledronic Acid Infusion in Brazilian Population with Osteoporosis
by: Bruno S. A. Ferreira, et al.
Published: (2021-01-01)

Diagnostic challenges of posterior scleritis in pembrolizumab treated patient for cutaneous melanoma: A case report
by: Fabrizio Sinisi, et al.
Published: (2024-12-01)

Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia
by: Weilong Li, et al.
Published: (2024-11-01)

Is There an Ideal Concentration of Ozonized Oil for the Prevention and Modulation of Zoledronate-Induced Mandibular Osteonecrosis? A Study on Senescent Rats
by: Mirela Caroline Silva, et al.
Published: (2024-11-01)

HRQoL Evaluation of Pediatric Osteogenesis Imperfecta with Zoledronic Acid Therapy
by: Tri Wahyu Martanto, et al.
Published: (2023-10-01)

Annual Zoledronic Acid for the Treatment of Osteoporosis: A Randomized Controlled Trial
by: Asif Hussain, et al.
Published: (2023-01-01)

Hyponatremia after intravenous zoledronic acid administration: A case report
by: Nafis Vural, et al.
Published: (2023-12-01)

Role of Denosumab and Zoledronic Acid in Geriatric Hip Fractures – A Comparative Analysis
by: P Madhuchandra, et al.
Published: (2024-01-01)

Single postoperative infusion of zoledronic acid to improve patient-reported outcome after hip or knee replacement: study protocol for a randomised, controlled, double-blinded clinical trial
by: Jonas Ranstam, et al.
Published: (2020-09-01)

Risk Factors for Acute Febrile Reaction after Zoledronic Acid Treatment for Primary Osteoporosis
by: WU Hongliang, et al.
Published: (2022-06-01)

Craniofacial Effects of Zoledronic Acid on the Osteogenesis Imperfecta Mouse (−/−) Model of Severe Osteogenesis Imperfecta
by: Gaspard Jeannerod, et al.
Published: (2024-11-01)

Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab
by: Roberto Benelli, et al.
Published: (2022-12-01)

LONG-ACTING ZOLEDRONIC ACID: ONCE-YEARLY ADMINISTRATION AND EFFICACY EVALUATION IN MYELOMA BONE DISEASE
by: Murat Çınarsoy
Published: (2024-12-01)

Evaluate the renal system damage caused by zoledronic acid: a comprehensive analysis of adverse events from FAERS
by: Zhaojun Wang, et al.
Published: (2024-12-01)

Sequential therapy with teriparatide following zoledronic acid in severe osteoporotic vertebral compression fracture: A case report
by: Xuanwei Wang, et al.
Published: (2024-12-01)

Cationic Hydroxyethyl Cellulose Nanocomplexes and RANK siRNA/Zoledronate Co-Delivery Systems for Osteoclast Inhibition
by: Sohyun Lee, et al.
Published: (2024-12-01)

Unilateral Anterior Scleritis Following the Booster Shot of Inactivated COVID-19 (Sinopharm) Vaccine in a 52-Year-Old Woman: A Case Report
by: Kimia Jazi, et al.
Published: (2024-01-01)

Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta
by: Jennifer Walsh, et al.
Published: (2023-11-01)

Zoledronic acid as adjuvant therapy in neovascular age-related macular degeneration: a randomised controlled pilot study
by: Øystein Kalsnes Jørstad, et al.
Published: (2024-12-01)

Geranylgeraniol (GGOH) as a Mevalonate Pathway Activator in the Rescue of Bone Cells Treated with Zoledronic Acid: An In Vitro Study
by: Riham M. Fliefel, et al.
Published: (2019-01-01)

The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis
by: Deepak Kumar Khajuria, et al.
Published: (2014-01-01)

Effects of Zoledronic Acid on Physiologic Bone Remodeling of Condylar Part of TMJ: A Radiologic and Histomorphometric Examination in Rabbits
by: Ufuk Tatli, et al.
Published: (2014-01-01)

Protocol for a pilot randomised controlled trial of zoledronic acid to prevent bone loss following sleeve gastrectomy surgery
by: Laura E Flores, et al.
Published: (2021-12-01)

Reduction effect of oral pravastatin on the acute phase response to intravenous zoledronic acid: protocol for a real-world prospective, placebo-controlled trial
by: Qi Liu, et al.
Published: (2022-07-01)

The effect of denosumab vs. zoledronic acid in preventing skeletal-related events, including pain-related bone metastasis: a systematic review
by: I. Putu Eka Widyadharma, et al.
Published: (2024-10-01)

Rare Form of Erdheim-Chester Disease Presenting with Isolated Central Skeletal Lesions Treated with a Combination of Alfa-Interferon and Zoledronic Acid
by: E. N. Bulycheva, et al.
Published: (2015-01-01)